Hyaluronic-acid based nanocarriers for RNAi therapy of advanced sepsis
Ever since the first representation of RNAi phenomenon in 1998, its ride has been quite complicated. If handled carefully, RNAi could have the potential of transforming into a therapeutic which can apply in a wide range of diseases from viral to cancer. The use of a powerful therapeutic tool like si...
| Published: |
|
|---|---|
| Online Access: | http://hdl.handle.net/2047/D20197272 |